Status:
RECRUITING
Clinical Retrospective Study Analysis of Postoperative Complications Following Hepatectomy
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Liver Failure
Liver Dysfunction
Eligibility:
All Genders
18-80 years
Brief Summary
Hepatectomy is a crucial surgical method for treating liver diseases such as liver cancer, hepatic hemangiomas, and biliary stones. Although hepatectomy has achieved significant therapeutic effects, p...
Eligibility Criteria
Inclusion
- 1\. Patients aged 18-80 years 2.Patients who underwent liver resection surgery at the participating centers
Exclusion
- Exclusion criteria are as follows:
- Prior cancer treatments such as transarterial chemoembolization, ablation, or targeted therapy.
- Repeat liver resection surgeries.
- Presence of other malignancies.
- Concurrent end-stage diseases including active infections, respiratory failure, decompensated heart failure, and autoimmune disease exacerbations.
- Inadequate clinical data availability in medical records.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06532214
Start Date
January 1 2024
End Date
December 31 2025
Last Update
August 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang Hospital
Guangzhou, Guangdong, China, 510515